# Companion Spine

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/companion-spine

- Industry: Healthcare
- Headquarters: New York, US
- Website: www.companion-spine.com
- Total disclosed funding: $60M
- Latest round: Series A (Mar 23, 2023)
- Investors on record: 3

## About

Based in New York, US, and founded in 2020 by CEO Erick Cloix, and Anthony G. Viscogliosi, Companion Spine LLC provides diagnostic, interventional, and surgical total solutions for relieving back pain as well as treatment of degenerative disc disease and lumbar spinal stenosis. In February 2022, Companion Spine raised USD 55 million in a Series A funding led by Viscogliosi Brothers.

Companion Spine offers interventional therapies and technologies for degenerative disc disease, spinal stenosis, injury-related pain, and general back pain. The company is developing tools and technologies for diagnosis, pain management, interventional therapies, and surgical technologies for pain treatment that might include reversible and invasive treatments that can be performed in outpatient centers.

The company plans to use its proceeds from a Series A funding to develop and commercialize its invasive diagnostic and therapeutic solutions in the US and worldwide for the treatment of spine diseases, such as degenerative disc disease (DDD) and lumbar spine stenosis (LSS).

## Funding rounds

- Series A, Mar 23, 2023, $5M — Viscogliosi Brothers, Viscogliosi Brothers Watermark Holdings, Epimed International, Inc.
- Series A, Feb 15, 2022, $55M — Viscogliosi Brothers

## Investors

- Viscogliosi Brothers (https://capitalatlas.ai/funds/viscogliosi-brothers) — Series A
- Viscogliosi Brothers Watermark Holdings (https://capitalatlas.ai/funds/viscogliosi-brothers-watermark-holdings) — Series A
- Epimed International, Inc. — Series A